Tencent-backed EV maker NIO said to price IPO at bottom of target range


The IPO priced at $6.25, at the low end of its $6.25 to $8.25 target price range, will value NIO at $6.4 billion

Hong Kong’s CKI gets green light to bid for Australia’s APA Group

The deal would make CKI, founded by Hong Kong tycoon Li Ka-shing, the major gas pipeline player in Australia.

HSBC to bolster Asia private banking headcount, double client assets

HSBC’s Asia private bank will add 700 people by 2022 from a headcount of 1,100 at the end of 2017.

Hong Kong-based CLP’s India arm buys 49% in two Suzlon solar projects

CLP has the option to acquire the balance 51% stake in the two solar projects, Gale and Tornado respectively, in future.

US-based Hustle Fund closes first $11.5m fund anchored by China’s Shanda, Line and Naver

Other investors include tech operators, founders and executives of Zappos, Optimizely and NerdWallet.

Finnish Amer Sports gets takeover bid from China’s Anta, FountainVest Partners

Amer has long been a target for Anta, which sells the Fila and Descente sportswear brands as well as its own home-grown Anta brand in China

China’s Hillhouse-backed consortium said to drop buyout plan of Yum China

The investor group, which also included KKR & Co and China’s sovereign wealth fund, has decided not to continue pursuing a deal after its initial proposal was rejected.

How Jack Ma became the role model for China’s startup generation

It was Alibaba’s record-setting initial public offering that altered the country’s tech industry for good.

Alibaba’s new boss: The finance vet who quietly shook things up

Jack Ma will step down as executive chairman of Alibaba Group Holding Ltd. in 2019, handing the reins to Daniel Zhang, who became chief executive officer barely three years ago. The 46-year-old certified accountant has been the driving force behind a mandate to transform old-school commerce using technology that it’s dubbed “ New Retail.”

Carlyle Asia fund invests in US pharma player Ambio

The buyout major acquired the stake from specialist healthcare fund, MVM Partners.